Oncology & Cancer

Updated recommendations for managing hereditary breast cancer

(HealthDay)—One year of adjuvant olaparib should be offered to patients with high-risk early-stage human epidermal growth factor receptor 2 (HER2)-negative breast cancer and germline BRCA mutations after completion of (neo)adjuvant ...

Diseases, Conditions, Syndromes

Healthcare after COVID: Racial disparities laid bare

Deidre Johnson spends her days leading a center that provides resources to help Black people in her community overcome health disparities and other societal challenges.

Diseases, Conditions, Syndromes

International recommendations for nontuberculous mycobacteria

NTMs are closely related to tuberculosis bacteria and can (but do not need to) cause infectious diseases in humans. They are called "nontuberculous mycobacteria" (NTMs) to distinguish them from tuberculosis bacteria. There ...

Health

Marketing makes dubious claims about infant formulas

Marketing claims promote benefits of providing infant formula and toddler milks that are not supported by scientific evidence, yet 60% of caregivers mistakenly believe these products provide nutrition not present in breastmilk, ...

page 1 from 2